Molly is an M.D./Ph.D. student in Cancer Biology in the NIH Medical Scientist Training Program. Molly received her Bachelor’s degree in Bioengineering from the University of Illinois Urbana-Champaign. Molly’s work showed that loss of the 7q gene, CUX1, disrupts epigenetic-driven DNA repair and causes therapy-related myeloid neoplasms. (Under review.) She was supported by the MSTP Training Grant NIH/NIGMS T32 GM007281 and also received the NIH/NCI Ruth L. Kirschstein National Research service award (F30 CA232673) “The role of Cux1 in the pathogenesis of therapy-related myeloid neoplasms.” She has been recognized by the 2019 FASEB Hematologic Malignancies Poster Presentation Award, 2019 BSD Travel Award, 2019 Graduate Council Travel Fund Award, 2019 American Society of Hematology Abstract Achievement Award, 2019 Elaine Ehrman Award, and the 2022 Leon O. Jacobson Basic Science Prize (MD/PhD students). She is currently finishing her M.D. at Pritzker Medical School.